A Location-Adaptive Four-Stage Hybrid Therapeutic Platform for Minimally Invasive Spatial Control of Glioblastoma (GBM) with Computational Simulation
Year: 2026
Type: preprint
Abstract: Glioblastoma (GBM) is an aggressive primary malignant brain tumor that infiltrates normal brain parenchyma along white matter tracts and perivascular spaces (contact guidance) without distinct anatomical borders, leading to frequent local recurrence near the resection margin. Moreover, anatomical constraints and recurrence pathways differ substantially between superficial cortical lesions (frontal, temporal, and parietal lobes) and deep-seated lesions (thalamus, basal ganglia, and periventricular regions). This paper proposes a location-adaptive, four-stage hybrid therapeutic platform designed for minimally invasive spatial control of GBM across any intracranial location, guided by preoperative diffusion tensor imaging (DTI) tractography. The protocol comprises: (1) MRI-monitored core cytoreduction (partial cryoablation or laser interstitial thermal therapy [LITT]) paired with slow fractional drainage; (2) 5-aminolevulinic acid (5-ALA) blue-light fiber-optic endoscopic margin verification and directional anti-adhesion barrier coating (Push) over eloquent neural tracts; (3) location-adaptive CXCL12 chemotactic motility trapping (Pull) via either an aligned polycaprolactone (PCL) nanofiber conduit leading to a subcutaneous extracortical trap (Mode A: superficial lesions) or a periventricular thermosensitive hydrogel trap coupled to an Ommaya reservoir (Mode B: deep-seated lesions), enabling safe physical extraction or replacement without injuring healthy brain tissue; and (4) 200 kHz deep cross-fire tumor-treating fields (TTFields), 5-ALA sonodynamic therapy (SDT), and trap-harvested neoantigen-based immunotherapy (CAR-T / mRNA vaccines). To bridge the gap before next-generation biomaterials receive full regulatory approval, a near-term clinical translation roadmap utilizing currently approved medical devices and drugs—alongside a modular working-sheath catheter architecture designed to lower regulatory barriers—is also presented. Keywords: Glioblastoma (GBM), Location-Adaptive Therapy, Partial Cryoablation, LITT, 5-ALA Fluorescence & Sonodynamic Therapy (SDT), PCL Nanofiber Trap, CXCL12 Chemotaxis, Ommaya Reservoir, Convection-Enhanced Delivery (CED), Tumor-Treating Fields (TTFields)
Author: Lee, Youngbae
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: glioblastoma, cryoablation, laser interstitial thermal therapy, 5-aminolevulinic acid, sonodynamic therapy, Ommaya reservoir, tumor treating fields, convection-enhanced delivery, diffusion tensor tractography, anti-adhesion barrier, deep-seated brain tumors, CAR T-cell therapy, mRNA vaccines, recurrent glioma
Open Access status: green
OpenAlex ID: W7226023779
